Cbdmd, Inc. (YCBD) — 10-Q Filings
All 10-Q filings from Cbdmd, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
cbdMD's Q3 Loss Widens Amid Sales Dip, Cash Shrinks
— Aug 14, 2025 Risk: high
cbdMD, Inc. (YCBD) reported a net loss attributable to common shareholders of $1,228,772 for the three months ended June 30, 2025, a significant increase from t -
cbdMD, Inc. Q2 2025: $783K Sales, $492K Net Loss
— May 15, 2025 Risk: medium
cbdMD, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $5,000,000 and total liabilities of $5,000,000 as of March -
cbdMD, Inc. Q1 FY25 Assets & Liabilities Revealed
— Feb 13, 2025 Risk: medium
For the first quarter of fiscal year 2025, ending December 31, 2024, cbdMD, Inc. reported total assets of $5,543,124 and total liabilities of $3,939,057. The co -
cbdMD Reports Q3 2024 Results: Net Loss Narrows
— Aug 14, 2024 Risk: medium
For the third quarter of fiscal year 2024, cbdMD, Inc. reported total assets of $50,000,000 and total liabilities of $5,000,000. The company's net loss for the -
cbdMD, Inc. Files 10-Q for Period Ending March 31, 2024
— May 15, 2024 Risk: medium
cbdMD, Inc. (YCBD) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Total revenue for the six months ended March 31, 2024, was $179,419. Net loss f -
cbdMD, Inc. Files 10-Q for Period Ending December 31, 2023
— Feb 13, 2024 Risk: medium
cbdMD, Inc. (YCBD) filed a Quarterly Report (10-Q) with the SEC on February 13, 2024. Net sales for the three months ended December 31, 2023, were $2,961,056. T
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX